BIOVENTUS INC. Deferred Federal Income Tax Expense (Benefit)
BIOVENTUS INC. (BVS) reported Deferred Federal Income Tax Expense (Benefit) of -$494.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-05
- BIOVENTUS INC. deferred federal income tax expense (benefit) for fiscal 2025 was -$494.00K.
- BIOVENTUS INC. deferred federal income tax expense (benefit) for fiscal 2024 was -$4.38M.
- BIOVENTUS INC. deferred federal income tax expense (benefit) for fiscal 2023 was -$2.88M.
- BIOVENTUS INC. deferred federal income tax expense (benefit) for fiscal 2022 was -$38.68M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$494.00K 10-K · filed 2026-03-05 | |
| 2024-12-31 | -$4.38M 10-K · filed 2026-03-05 | |
| 2023-12-31 | -$2.88M 10-K · filed 2026-03-05 | |
| 2022-12-31 | -$38.68M 10-K · filed 2025-03-11 | -$42.05M 10-K · filed 2023-03-31 |
| 2021-12-31 | -$9.02M 10-K · filed 2024-03-12 | |
| 2020-12-31 | -$508.00K 10-K · filed 2023-03-31 | |
| 2019-12-31 | -$345.00K 10-K · filed 2022-03-11 |